292 related articles for article (PubMed ID: 24277152)
1. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.
Malbec M; Porrot F; Rua R; Horwitz J; Klein F; Halper-Stromberg A; Scheid JF; Eden C; Mouquet H; Nussenzweig MC; Schwartz O
J Exp Med; 2013 Dec; 210(13):2813-21. PubMed ID: 24277152
[TBL] [Abstract][Full Text] [Related]
2. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
3. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
4. HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
Ducloy C; Su B; Mayr L; Klingler J; Decoville T; Schmidt S; Laumond G; Salomé N; Bahram S; Moog C
AIDS; 2018 Jun; 32(10):1239-1245. PubMed ID: 29683853
[TBL] [Abstract][Full Text] [Related]
5. Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission.
Luo X; Mouquet H; Schwartz O; Greene WC
J Biol Chem; 2021 Oct; 297(4):101098. PubMed ID: 34418431
[TBL] [Abstract][Full Text] [Related]
6. Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.
Dufloo J; Planchais C; Frémont S; Lorin V; Guivel-Benhassine F; Stefic K; Casartelli N; Echard A; Roingeard P; Mouquet H; Schwartz O; Bruel T
Nat Commun; 2022 Feb; 13(1):630. PubMed ID: 35110562
[TBL] [Abstract][Full Text] [Related]
7. Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.
Su B; Peressin M; Ducloy C; Penichon J; Mayr LM; Laumond G; Schmidt S; Decoville T; Moog C
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1187-91. PubMed ID: 26252799
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing antibodies potently inhibit cell-to-cell transmission of semen leukocyte-derived SHIV162P3.
Suphaphiphat K; Tolazzi M; Hua S; Desjardins D; Lorin V; Dereuddre-Bosquet N; Mouquet H; Scarlatti G; Grand RL; Cavarelli M
EBioMedicine; 2020 Jul; 57():102842. PubMed ID: 32619962
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.
Dufloo J; Bruel T; Schwartz O
Retrovirology; 2018 Jul; 15(1):51. PubMed ID: 30055632
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody.
van Montfort T; Thomas AA; Krawczyk PM; Berkhout B; Sanders RW; Paxton WA
J Immunol; 2015 Oct; 195(8):3759-68. PubMed ID: 26355155
[TBL] [Abstract][Full Text] [Related]
11. Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.
Reh L; Magnus C; Schanz M; Weber J; Uhr T; Rusert P; Trkola A
PLoS Pathog; 2015 Jul; 11(7):e1004966. PubMed ID: 26158270
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.
Sagar M; Akiyama H; Etemad B; Ramirez N; Freitas I; Gummuluru S
J Infect Dis; 2012 Apr; 205(8):1248-57. PubMed ID: 22396600
[TBL] [Abstract][Full Text] [Related]
13. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
14. eCD4-Ig Variants That More Potently Neutralize HIV-1.
Fetzer I; Gardner MR; Davis-Gardner ME; Prasad NR; Alfant B; Weber JA; Farzan M
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593050
[TBL] [Abstract][Full Text] [Related]
15. eCD4-Ig Limits HIV-1 Escape More Effectively than CD4-Ig or a Broadly Neutralizing Antibody.
Fellinger CH; Gardner MR; Weber JA; Alfant B; Zhou AS; Farzan M
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068428
[TBL] [Abstract][Full Text] [Related]
16. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
17. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
Zhang Y; Chapman JH; Ulcay A; Sutton RE
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
[TBL] [Abstract][Full Text] [Related]
18. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
19. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
[TBL] [Abstract][Full Text] [Related]
20. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
Morgand M; Bouvin-Pley M; Plantier JC; Moreau A; Alessandri E; Simon F; Pace CS; Pancera M; Ho DD; Poignard P; Bjorkman PJ; Mouquet H; Nussenzweig MC; Kwong PD; Baty D; Chames P; Braibant M; Barin F
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):237-45. PubMed ID: 26413851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
